🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Browsing Tag

Morgan Stanley

123 posts
Read More

Oura files Nasdaq IPO as $11bn valuation meets profit surge

Oura has filed for a Nasdaq IPO after nine-month revenue jumped 74% to $1.21 billion and net income reached $60.8 million. The smart-ring company has 5 million paying members and membership gross margins of 89%, but hardware still produces 80% of revenue. Its public-market test is whether investors value Oura as a consumer-device maker or a recurring health-intelligence platform.
Read More

USI nearly tripled revenue under KKR, but Aon is paying 14.5 times synergised EBITDA for the next stage

Aon is paying $17 billion for privately held USI Insurance Services only two years after its $13 billion NFP acquisition. The transaction gives KKR a sixfold return on its original 2017 equity, but Aon’s 9.5% share-price fall shows investors are focusing just as closely on leverage, a 14.5-times synergised EBITDA multiple and the cost of integrating another major insurance brokerage.
Read More

Bamboo Insurance has $879m of managed premium, but its IPO comes with a $548m debt question

CVC-backed Bamboo Insurance Services has filed for a New York Stock Exchange listing after managed premium approached $879 million and first-half revenue grew 40%. The capital-light insurance model is producing strong adjusted margins, but a $548 million term loan, declining GAAP profit and catastrophe exposure will make the eventual IPO price critical.